• English
  • العربية
  • 中文
  • Français
  • Русский
  • Español

You are here

Production and Quality Control of Actinium-225 Radiopharmaceuticals

IAEA-TECDOC-2057

English IAEA-TECDOC-2057 ¦ 978-92-0-121324-2

54 pages ¦ 20 figures ¦ € 30.00 ¦ Date published: 2024

https://doi.org/10.61092/iaea.95h3-2ji2

Download PDF (2.18 MB)

Description

This publication includes existing experiences, lessons learned, challenges and future developments in the production of Ac-225 radiopharmaceuticals for Targeted Alpha Therapy (TAT). This publication will be utilized by all involved professionals in the Targeted Alpha Therapy field, specifying ideal production, formulation, quality control and regulatory aspects of various Ac-225 radiopharmaceuticals. The intended audience also includes radiochemists, radiopharmacists, and medical physicists.

More Information on reusing IAEA copyright material.

Stay in touch

Newsletter